Rochester, NY 7/10/2009 1:37:25 AM
WhisperfromWallStreet.com Afternoon Stock Report - KG - King Pharma, Pain Therapeutics to resubmit Remoxy
King Pharmaceuticals Inc.,KG
WhisperfromWallStreet.com Afternoon Stock Report - KG - King Pharma, Pain Therapeutics to resubmit Remoxy
King Pharmaceuticals Inc.,KG
Last Trade: 9.03
Day's Range: 8.98 - 9.28
52wk Range: 5.86 - 12.60
Volume: 2,833,230
King Pharmaceuticals Inc. and partner Pain Therapeutics Inc. said Tuesday they expect to resubmit an application for the pain drug candidate Remoxy with the Food and Drug Administration in the middle of 2010.
47.19 Up 2.09 (4.63%) 2:12PM ET
ABOUT THE COMPANY
King Pharmaceuticals, Inc. research and develops, manufactures, markets, and sells branded prescription pharmaceutical products and animal health products worldwide. The company's branded prescription pharmaceuticals include neuroscience products, such as Skelaxin, Avinza, and Sonata; hospital products, including Thrombin-JMI and Synercid; acute care products that comprise Bicillin and Intal; and legacy products consisting of Altace, Levoxyl, and Cytomel to general/family practitioners, internal medicine physicians, neurologists, pain specialists, surgeons, and hospitals. Its animal health business focuses on medicated feed additives (MFAs) and water-soluble therapeutics, which are anti-infective products primarily for poultry, cattle, and swine markets.ocuses on copper, gold, silver, cobalt, and molybdenum deposits. The company's portfolio of assets includes the Grasberg minerals district in Indonesia; mining operations in North and South America; and the Tenke Fungurume development project in the Democratic Republic of Congo. As of December 31, 2008, its consolidated recoverable proven and probable reserves included 102.0 billion pounds of copper, 40.0 million ounces of gold, 2.48 billion pounds of molybdenum, 266.6 million ounces of silver, and 0.7 billion pounds of cobalt. The company was founded in 1987 and is headquartered in Phoenix, Arizona.
---
There are hundreds of stocks that rise and fall each day, our expertise is understanding which have the best opportunity for rapid growth. Our newsletter has sent out over 40 alerts this year with an average price gain of 80%. If you like to be alerted to the stocks that meets our criteria. Please join us for free to track our results.
You can sign up now for free stock alerts at WhisperfromWallStreet.com
---
Please read the COMPLETE DISCLAIMER posted on our website.
IMPORTANT NOTE: This is not a solicitation to buy or sell any securities. Neither WhisperfromWallStreet.com, nor any of its affiliates are registered investment advisors or a broker dealer. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
